Episode Description
In this episode of It Takes Balls, Dr. Darren Feldman, a genitourinary medical oncologist at Memorial Sloan Kettering Cancer Center, provides a deep, evidence-based conversation on testicular cancer treatment, chemotherapy decision-making, and long-term survivorship. Dr. Feldman breaks down how cisplatin transformed testicular cancer from a fatal disease into one of the most curable solid tumors, even in cases of metastatic disease.
The discussion explores the differences between BEP, EP, VIP, and TIP chemotherapy regimens, including when and why each is used, how doctors balance cure rates with toxicity, and why lung health, kidney function, age, and patient goals matter when choosing treatment. Dr. Feldman also explains why cisplatin remains superior to carboplatin in advanced germ cell tumors, when surveillance is preferred over treatment in stage 1 disease, and how overtreatment can carry long-term risks.
Later in the episode, Dr. Feldman addresses common patient concerns around recurrence risk, radiation vs surveillance, retroperitoneal lymph node dissection (RPLND), testosterone changes after chemotherapy, and misinformation surrounding alternative therapies.
Provide your feedback on the podcast:
https://www.testicularcancerawarenessfoundation.org/itbsurvey
Have a question for a future expert guest? Submit here:
https://www.testicularcancerawarenessfoundation.org/it-takes-balls-question-submission
Want to be a guest? Apply here:
https://www.testicularcancerawarenessfoundation.org/it-takes-balls-submissions
Follow Testicular Cancer Awareness Foundation:
https://www.twitter.com/testescancer
https://www.instagram.com/testescancer
https://www.facebook.com/tca.org
Dr. Feldman:
https://www.mskcc.org/cancer-care/doctors/darren-feldman
Follow Steven Crocker:
https://www.instagram.com/stevencrocker
https://www.facebook.com/steven.crocker2
Theme song: No Time Like Now - Tom Willner www.tomwillner.com